首页 | 本学科首页   官方微博 | 高级检索  
     

敲减CCAAT/增强子结合蛋白α通过增加O-GlcNAc糖基化水平促进肝癌细胞体外增殖*
引用本文:李文姣,曹海超,马澜婧,张松,丁美玲,张浩浩,聂勇战. 敲减CCAAT/增强子结合蛋白α通过增加O-GlcNAc糖基化水平促进肝癌细胞体外增殖*[J]. 实用肝脏病杂志, 2018, 21(3): 393-396. DOI: 10.3969/j.issn.1672-5069.2018.03.019
作者姓名:李文姣  曹海超  马澜婧  张松  丁美玲  张浩浩  聂勇战
作者单位:710032 西安市 空军军医大学西京消化病医院肿瘤生物学国家重点实验室
基金项目:*国家杰出青年科研基金资助项目(编号:81225003)
摘    要:目的 探讨CCAAT/增强子结合蛋白α(C/EBPα)在肝癌细胞增殖中的作用及其机制。方法 利用靶向C/EBPα的RNAi慢病毒感染Hep3B肝癌细胞系,构建C/EBPα肝癌细胞系敲减模型。采用qRT-PCR和Western blot分别检测C/EBPα mRNA和蛋白表达水平,采用CCK-8检测敲减C/EBPα后对Hep3B细胞增殖的影响,采用在正常高葡萄糖(NG,4.5 g/L)和低葡萄糖(LG,1 g/L)条件下培养细胞的增殖变化,采用Western blot法检测不同葡萄糖浓度条件下在C/EBPα敲减细胞和对照细胞乙酰葡糖胺转移酶(OGT)、乙酰葡糖胺水解酶(OGA)和整个O-GlcNAc糖基化水平。结果 靶向C/EBPα的RNAi慢病毒感染Hep3B肝癌细胞后,C/EBPα mRNA水平下调了(7.5±2.3)倍(P<0.05),蛋白表达水平下调了(8.8±0.25)倍(P<0.001),提示C/EBPα敲减细胞系构建成功;敲减C/EBPα后明显促进肝癌细胞的体外增殖;在低葡萄糖条件下刺激48 h和72 h,敲减C/EBPα分别促进细胞增殖15.4%(P<0.05)和25.0%(P<0.01);敲减C/EBPα后细胞OGA蛋白表达水平在正常高糖和低糖刺激24 h和48 h时分别下调了70.1% (P<0.01)、51.4%(P<0.05)和61.2%(P<0.05),整体O-GlcNAc糖基化表达水平上调,在低糖刺激48 h时升高80.6%。结论 敲减转录因子C/EBPα可以提高细胞整体O-GlcNAc糖基化水平,从而促进肝癌细胞的体外增殖。

关 键 词:肝细胞癌  CCAAT/增强子结合蛋白α  O-GlcNAc糖基化  体外  
收稿时间:2017-10-06

Downregulation of CCAAT/enhancer-binding protein alpha promotes growth of hepatocellular carcinoma cells in vitro by increasing O-GlcNAcylation
Li Wenjiao,Cao Haichao,Ma Lanjing,et al. Downregulation of CCAAT/enhancer-binding protein alpha promotes growth of hepatocellular carcinoma cells in vitro by increasing O-GlcNAcylation[J]. Journal of Clinical Hepatology, 2018, 21(3): 393-396. DOI: 10.3969/j.issn.1672-5069.2018.03.019
Authors:Li Wenjiao  Cao Haichao  Ma Lanjing  et al
Affiliation:State Key Laboratory of Cancer Biology,Xijing Hospital of Digestive Disease,Affiliated to Fourth Military Medical University,Xi'an,710032,China
Abstract:Objective To explore the roles and potential mechanism of CCAAT/enhancer-binding protein alpha (C/EBPα) in the growth of hepatocellular carcinoma (HCC) cells in vitro. Methods The Hep3B cells were transfected with RNAi lentivirous,and the mRNA and protein of C/EBPα were detected by qRT-PCR and Western blot respectively. The growth of HCC cells in normal glucose (NG,4.5 g/L) and low glucose(LG,1 g/L) were assessed by CCK-8 assay and quantified based on the absorbance value at OD450. The protein levels of O-GlcNAcase(OGA),O-GlcNAc transferase(OGT) and the whole O-GlcNAcylation in normal glucose and low glucose were detected by Western blot. Results The C/EBPαmRNA level was down-regulated by(7.5±2.3) folds(P<0.05) and its protein was decreased by (8.8±0.25) folds (P<0.001) in transfected with RNAi lentivirous cells (sh-C/EBPα) compared with control cell (sh-Con). Knocking down C/EBPα promoted the growth of HCC cells in vitro. The growth rates of sh-C/EBPα cells increased by 15.4% (P<0.05) and 25.0% (P<0.01) in low glucose(LG,1 g/L) condition at 48 hours and 72 hours;The protein of OGA decreased by 70.1% (P<0.01),51.4%(P<0.05) and 6 1.2% (P<0.05) in normal gulucose,low glucose at 24 h and 48 h. Whole O-GlcNAcylation was up-regulated by 80.6% in the C/EBPα knocked-down cells in low glucose at 48 h. Conclusion s The downregulation of CCAAT/enhancer-binding protein alpha promotes the growth of hepatocellular carcinoma cells in vitro likely by increasing O-GlcNAcylation in some extent.
Keywords:Hepatoma  CCAAT/enhancer-binding protein alpha  O-GlcNAcylation  In vitro  
本文献已被 CNKI 等数据库收录!
点击此处可从《实用肝脏病杂志》浏览原始摘要信息
点击此处可从《实用肝脏病杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号